DR. INFOvsOpenEvidenceUpdated 16 October 2026

OpenEvidence in Spain: is it available, and what do Spanish doctors use instead? (2026)

The best OpenEvidence alternative in Spain is DR. INFO: a clinical AI built in Europe and hosted in the EU that writes a cited answer in Spanish from guidelines and literature, and can be used from Spain now that OpenEvidence has ended access from the EU. OpenEvidence terminated app access in the EU and the UK on 28 April 2026, citing regulatory uncertainty around European AI rules, and access from Spanish and other European addresses has been blocked since [1][2]. There was never a Spanish version: OpenEvidence answered in English from US-oriented sources. The 322,787 médicos colegiados that the Instituto Nacional de Estadística counted for 2025 [3] still have the free national references: the clinical practice guidelines catalogued by GuíaSalud for the Sistema Nacional de Salud [4] and the CIMA drug information centre of the AEMPS [5], both written to be consulted rather than to answer a question about the patient in front of you. On OpenAI's HealthBench Hard, DR. INFO scored 0.72 against OpenEvidence's 0.49 on the same 100 examples [6][7]. This page is written in English because most Spanish clinicians search for OpenEvidence under its English name; DR. INFO itself answers in Spanish. It covers what happened, what remains in Spain, and how the options compare for a médico de familia or a hospital specialist.

DR. INFO and OpenEvidence, side by side

Available in Spain

DR. INFO Yes, on the web and the iPhone app

OpenEvidence No, access from the EU ended 28 April 2026

Answers in Spanish

DR. INFO Yes, in the language you ask in

OpenEvidence No, English only

How it answers

DR. INFO A written answer built from retrieved guidelines and literature, each statement cited

OpenEvidence A written answer with citations, US-oriented sources

Data hosting

DR. INFO European Union, under GDPR

OpenEvidence United States

Guideline sources

DR. INFO European and national guidelines, retrieved per question; the GuíaSalud guidelines are public and can be asked about

OpenEvidence US-centred

Drug information

DR. INFO FDA and EMA authorised sources, EMA SmPC; CIMA remains the Spanish reference

OpenEvidence US sources

Documentation

DR. INFO Scribe with SOAP notes and discharge letters in the same product

OpenEvidence None

Regulatory status

DR. INFO CE marked medical device under EU MDR 2017/745, which applies directly in Spain

OpenEvidence Not CE marked

HealthBench Hard (same 100 examples)

DR. INFO 0.72

OpenEvidence 0.49

Cost

DR. INFO Free tier, paid plans

OpenEvidence Was free for verified clinicians

How DR. INFO compares with OpenEvidence

DR. INFO and OpenEvidence on HealthBench Hard

Rubric graded scores on difficult, open ended clinical conversations, from the same 100 example run. Higher is better.

0.250.500.751.000.72DR. INFO0.49OpenEvidence

Source: Ravichandran S, et al. OpenAI’s HealthBench in Action. arXiv:2509.02594.

Frequently asked questions

Is OpenEvidence available in Spain in 2026?
No. OpenEvidence terminated app access in the EU and the UK on 28 April 2026, and access from Spanish and other European addresses has been blocked since. The company cited regulatory uncertainty around European AI rules. No return date has been announced.
Is there a Spanish version of OpenEvidence?
No. OpenEvidence never answered in Spanish or offered a Spanish interface, and its sources were US-oriented. Searches for OpenEvidence en español lead back to the April 2026 withdrawal. DR. INFO answers in the language you ask in, so a question in Spanish gets a cited answer in Spanish.
Does the OpenEvidence app still work in Spain?
No. The app can be installed, but sign-in and access from EU addresses have been blocked since April 2026, in the app and in the browser alike. DR. INFO works in the browser at app.drinfo.ai and on the iPhone app, from Spain without workarounds.
When will OpenEvidence come back to Spain?
There is no date. The withdrawal was tied to European AI regulation, whose obligations for medical AI phase in through 2027, so a return would be a decision by the company rather than a technical fix. A clinician who needs a cited answer today is better off not waiting for it.
Why did OpenEvidence leave Europe?
OpenEvidence withdrew from the EU and the UK together, citing uncertainty about European AI regulation, including the EU AI Act. Commentary in the medical press has treated the move as a sign of the regulatory divide between US health AI and European rules [8].
What do Spanish doctors use instead of OpenEvidence?
Two kinds of tool. The free Spanish references: the guías de práctica clínica catalogued by GuíaSalud for the Sistema Nacional de Salud [4], the CIMA drug information centre of the AEMPS with every authorised ficha técnica [5], and the guidelines of the scientific societies, all written to be consulted. And DR. INFO, a European clinical AI that answers a clinical question in Spanish with citations you can open, hosts data in the EU, and includes a scribe and discharge letter drafting.
Is DR. INFO the best OpenEvidence alternative for Spanish doctors?
For a clinician who wants what OpenEvidence did, a cited written answer to a clinical question, DR. INFO is the closest fit that can be used from Spain: it retrieves guidelines and literature for each question, cites every statement, hosts data in the EU, answers in Spanish and scored 0.72 against OpenEvidence's 0.49 on HealthBench Hard.
How does DR. INFO cite its answers?
Each answer is written from documents retrieved for that question, and each statement carries a citation that opens the source: a guideline, a peer reviewed paper, or an FDA or EMA drug document. That makes the answer checkable in the way a colleague's summary is not. In a prospective pilot study published in Cureus in 2026, physicians using DR. INFO at the point of care rated that traceability as part of its value [9].
Can DR. INFO answer questions about Spanish guidelines?
The guidelines catalogued by GuíaSalud and those published by the Spanish scientific societies are public documents, so DR. INFO can be asked about them and cites the source it used in the answer; with the country set to Spain, national recommendations are preferred, and European guidelines from bodies such as the ESC and ESMO are always included. Coverage is broad but not complete for any single society. DR. INFO is not affiliated with GuíaSalud or the societies, and the current guideline on their websites remains the version to rely on.
Where is DR. INFO's data hosted, and what does that mean for a Spanish practice?
DR. INFO is hosted in the European Union under GDPR, which Spain applies through the LOPDGDD with the Agencia Española de Protección de Datos as supervisory authority [10]. Asking a clinical question without patient identifiers does not transfer health data. Whether a tool may be used with identifiable patient data remains a decision for each hospital, centro de salud or consulta, with its delegado de protección de datos and, where needed, an impact assessment.
Is DR. INFO free for doctors in Spain?
There is a free tier for doctors, residentes and medical students, with paid plans for heavier use. It works in the browser at app.drinfo.ai and on the iPhone app, from Spain without restriction.
Does DR. INFO answer in Spanish?
Yes. Ask in Spanish and the answer comes back in Spanish, with the same cited sources; ask in English, Catalan or Portuguese and it answers in that language. The product interface is currently available in English, German, Dutch and Portuguese.
Is DR. INFO a certified medical device?
Yes. DR. INFO is CE marked under EU MDR 2017/745 [11], which applies directly in Spain with the AEMPS as the competent authority, and is developed and operated by Synduct GmbH in Munich.

OpenEvidence is not coming back to Spain on any announced date, there was never a Spanish version, and GuíaSalud and CIMA were never an answer engine. For a Spanish clinician who wants a cited answer to a clinical question in Spanish, DR. INFO is the tool to try first: built in Europe, hosted in the EU, free to start, and scoring higher than OpenEvidence on the hardest public benchmark of clinical answers.

References

  1. 1.Breaking: OpenEvidence app access terminated in the UK and EU. Telehealth and Telecare Aware. 28 April 2026.
  2. 2.The US-based medical search engine OpenEvidence is down in Europe: a commentary on regulatory complexities. Intelligence-Based Medicine. 2026.
  3. 3.Instituto Nacional de Estadística. Estadística de Profesionales Sanitarios Colegiados, año 2025. Press release, May 2026.
  4. 4.GuíaSalud. Catálogo de Guías de Práctica Clínica en el Sistema Nacional de Salud.
  5. 5.AEMPS. CIMA: Centro de Información online de Medicamentos.
  6. 6.Ravichandran S, Kumar S, Corga Da Silva R, Romano M, et al. OpenAI’s HealthBench in Action: Evaluating an LLM-Based Medical Assistant on Realistic Clinical Queries. arXiv:2509.02594. 2026.
  7. 7.Arora RK, Wei J, Soskin Hicks R, et al. HealthBench: Evaluating Large Language Models Toward Improved Human Health. OpenAI. 2025.
  8. 8.OpenEvidence exits Europe, highlighting divide in health AI rules. Telehealth.org. 2026.
  9. 9.Corga Da Silva R, Romano M, Mendes T, et al. DR. INFO at the Point of Care: A Prospective Pilot Study of Physician-Perceived Value of an Agentic Artificial Intelligence Clinical Assistant. Cureus. 2026.
  10. 10.Agencia Española de Protección de Datos (AEPD).
  11. 11.Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (EU MDR). Official Journal of the European Union. 2017.